February 2027

3 medicines lose their last listed patent or exclusivity in February 2027.

1. Feb 2Lexiscanregadenoson · Astellas Pharma US Inc
2. Feb 24Colazalbalsalazide disodium · Valeant Pharmaceuticals International
3. Feb 28Advil Allergy Sinuschlorpheniramine maleate, ibuprofen and pseudoephedrine hydrochloride · Haleon US Holdings LLC